Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone plus prednisone in metastatic castration-resistant prostate cancer
CTR20132149Phase 3Completed
- Sponsor
- Cougar Biotechnology
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of abiraterone in metastatic castration-resistant prostate cancer (mCRPC), sponsored by Cougar Biotechnology. Started Jan 2015; status: completed.
02
Drugs
abiraterone
03
Conditions
metastatic castration-resistant prostate cancer (mCRPC)
Beyond the preview
Go deeper on CTR20132149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132149.